Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma

NCT01593696 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

NIH

Sponsor class

Conditions

ALL
B Cell Lymphoma
Leukemia
Large Cell Lymphoma
Non-Hodgkin Lymphoma

Interventions

BIOLOGICAL: Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR)

Sponsor

National Cancer Institute (NCI)